Navigation Links
Interleukin Genetics Announces Conference Call and Webcast to Discuss Second Quarter 2008 Business Results
Date:8/6/2008

WALTHAM, Mass., Aug. 6 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI), announced today that it will host a conference call and webcast on Wednesday, August 13, 2008, at 8:30 a.m. EDT to review the Company's second quarter 2008 financial results and provide an update on recent corporate developments.

To access the live call, dial 877-675-4751 (domestic) or 719-325-4910 (international). The live webcast and replay access of the teleconference will be available on the Investors section of the Company's website at http://www.ilgenetics.com.

About Interleukin Genetics

Interleukin Genetics, Inc. (Amex: ILI) is a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market. Focused on the future of health and medicine, Interleukin Genetics uses its leading genetics research and scientific capabilities to develop and test innovative preventive and therapeutic products. Interleukin Genetics has developed and commercialized genetic tests for risk assessment of coronary artery disease, periodontal disease, and general nutrition. The Company currently offers an array of Nutraceuticals and OTCeuticals(R), including Ginkoba(R), Ginsana(R) and Venastat(R) which are sold at the nation's largest food, drug and mass retailers. Interleukin is headquartered in Waltham, MA. For more information about Interleukin Genetics and its ongoing programs, please
'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Interleukin Genetics Announces Management and Board Appointments
2. Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference
3. Interleukin Genetics, Inc. Reports Third Quarter 2007 Financial Results
4. Interleukin Genetics Announces Conversion of $2.04 Million of Debt Into Common Stock
5. Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor
6. Interleukin Genetics Retains Top Life Science Communications Firms
7. Interleukin Genetics Announces Conference Call and Webcast to Discuss Fourth Quarter and Year End 2007 Business Results
8. Interleukin Genetics Appoints Eliot M. Lurier Chief Financial Officer
9. Interleukin Genetics Announces Conference Call and Webcast to Discuss First Quarter 2008 Business Results
10. Interleukin Genetics to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
11. Interleukin Genetics Welcomes the Signing of the Genetic Information Nondiscrimination Act (GINA)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... BEIJING, Nov. 25 /PRNewswire-Asia/ -- Sinovac B...er of vaccines, announced today that it executed,a... (Dalian) Vaccine,Technology Co., Ltd. (Sinovac Da...commercialize human-use vaccines. Sinovac will con... and commercializing world-class vaccines; the,oth...
(Date:11/24/2009)...vailable in German . , Whether it,s CD pack...gs (Radio Frequency Identification) are increasing... it possible to label objects or goods and identif...priate scanner can read and process the data conta...goods under production conditions of up to 100 deg...
(Date:11/24/2009)... The New York investment bank KTA Capital,s c...eed an AU$6.7 mil convertible note private placeme... placement was arranged by KTA Capital as Neuren,s... New York (PRWEB) November 23, 200...Capital, LLC ("KTA Capital") has announc...
(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswi...GN ) today announced that it has received notice f...mpany,s common stock will be,suspended as of Novem...the,Securities and Exchange Commission, which will...aq, unless the company files an appeal to the Nasd...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3
... Blue Cross/Blue Shield in fourteen states establi...file, SOUTH SAN FRANCISCO, Calif., Aug. 20 Monog...nced that Wellpoint, Inc. has,established a nation...,Assay., Wellpoint,s guidelines provide that HIV ...ly necessary for selecting individuals for treatme...
...DE, Calif. The majority of researchers working wi... produce any type of specialized adult cells in th...ring the cells. But because these materials are a... pathogens to the hESCs, making the cells unsuitab...at UC Riverside has devised a method of growing hE...
...racts Valued at $115.5 Million Signed in Fourth Qu...orated (Nasdaq: ARAY ), a global leader in the fi...lts for the fourth quarter and fiscal year,ended J...008, Accuray reported total revenue,of $50.9 milli...iscal 2007,total revenue of $44.0 million. For the...
Other Biology Technology:Medical Policy Guideline for Trofile(TM) Established By Wellpoint, Inc. 2Medical Policy Guideline for Trofile(TM) Established By Wellpoint, Inc. 3Medical Policy Guideline for Trofile(TM) Established By Wellpoint, Inc. 4UC Riverside researcher develops novel method to grow human embryonic stem cells 2UC Riverside researcher develops novel method to grow human embryonic stem cells 3Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 2Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 3Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 4Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 5Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 6Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 7Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 8Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 9
(Date:11/26/2009)... Prized for their impressive antlers, red deer hav...ns. But a deer,s antlers are much more than decora...ether when duelling. John Currey, from The Univers...cal properties of bone for over half a century and...s of antler through a long-standing collaboration ...
(Date:11/26/2009)... A survey carried out in eight European countries ...infectious disease pandemic could have a significa...ers writing in the open access journal BMC Infect...n on school days and weekends/holidays, finding th...el Hens, from Hasselt and Antwerp University, Belg...
(Date:11/26/2009)..., Heidelberg, 27 November 2009 What are the ba...ts required to produce a cell that can survive on ...a cell, and understand how an entire organism func...tions that scientists in a partnership between the...eidelberg, Germany, and the Centre de Regulacio Ge...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2School closure could reduce swine flu transmission by 21 percent 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Broad Coalition Says Consumer Role Is Key to Improving Health and Health Care 50066 1Broad Coalition Says Consumer Role Is Key to Improving Health and Health Care 50066 2Broad Coalition Says Consumer Role Is Key to Improving Health and Health Care 50066 3Broad Coalition Says Consumer Role Is Key to Improving Health and Health Care 50066 4Bills Address Long Waits for Behavioral Health Patients 50063 1Bills Address Long Waits for Behavioral Health Patients 50063 2Bills Address Long Waits for Behavioral Health Patients 50063 3MIT is pleased to announce that it has received a US 24 500 000 private placement from its Chinese partners 12787 1MIT is pleased to announce that it has received a US 24 500 000 private placement from its Chinese partners 12787 2
... stored under low oxygen conditions is related to ...g to a study published March 7th in the open-acces... at the Catholic University of Leuven in Belgium s...e long-term storage of fruit under controlled atmo...rcially stored under low oxygen conditions to exte...
...newly defined biochemical pathway in plants may pr...ill yield larger quantities of alternative transpo...rding to Purdue University researchers. , The pat... size through a system of signaling proteins, said...ologist. By learning more about the growth and dev...
...08. Forests can serve society in numerous waysby p...d recreational opportunities, for example. Managem...on of the USDA Forest Service. In May 2007, the ag..., Alaska, for silviculturists, forest practitioner... new ideas in silviculture and forest management t...
Other Biology News:Newly defined signaling pathway could mean better biofuel sources 2Newly defined signaling pathway could mean better biofuel sources 3Newly defined signaling pathway could mean better biofuel sources 4
Chlamydia trachomatis IgA ELISA Kit, Single from Bio-Quant Inc.
Chlamydia pneumonia IgM ELISA Kit, Single from Bio-Quant Inc.
Mouse IgM EIA Kit from Assay Designs/Stressgen Bioreagents
Custom Human Cytokine Antibody Array, Choose from hundreds of proteins. from Raybiotech, Inc.
Biology Products: